Gabapentin Pediatric Dose — Neuropathic Pain
Gabapentin is a structural analogue of gamma-aminobutyric acid (GABA) that modulates voltage-gated calcium channels to reduce excitatory neurotransmission. It is used in pediatric patients for the management of neuropathic pain conditions, including chronic pain syndromes and pain associated with nerve injury. Its slow, weight-based titration schedule helps minimize dose-dependent adverse effects such as sedation and dizziness.
Pediatric Dosing
Neuropathic Pain — Children
- Day 1: 5 mg/kg/dose once daily
- Day 2: 5 mg/kg/dose twice daily
- Day 3: 5 mg/kg/dose three times daily
- Titrate to effect. Usual maintenance range: 3–12 mg/kg/dose three times daily
Doses are administered orally. Titration is intentionally gradual to minimize CNS side effects. Consult institutional protocol for maximum single-dose and total daily dose limits in pediatric patients.
Worked example — 20 kg child at maintenance (mid-range 8 mg/kg/dose): 20 × 8 mg/kg = 160 mg per dose, given three times daily (480 mg/day total).
Adults
- Initial: 100 mg/dose three times daily
- Titration: Increase by 100 mg/dose weekly as tolerated
- Usual range: 600–800 mg/dose three times daily
Indications and Clinical Context
Gabapentin is indicated for the management of neuropathic pain in pediatric patients, a category of pain arising from injury or dysfunction of the somatosensory nervous system. Common pediatric etiologies include chemotherapy-induced peripheral neuropathy, complex regional pain syndrome, and post-surgical neuropathic pain. Its use in children is generally guided by specialist or pain service teams given the need for individualized weight-based titration.
Gabapentin is not a first-line agent for acute nociceptive pain and should be distinguished from analgesics used in standard PALS resuscitation protocols. It is best employed as part of a multimodal pain management strategy, particularly when neuropathic features (e.g., burning, allodynia, dysesthesia) are prominent. Dosing in children is extrapolated largely from adult data and clinical experience; institutional guidelines should be consulted for specific patient populations.
Administration and Monitoring
Gabapentin is administered orally and is available as capsules, tablets, and an oral solution. The three-day titration schedule (once, then twice, then three times daily dosing) should be followed to reduce the risk of sedation, ataxia, and dizziness. Doses should be spaced approximately 8 hours apart when given three times daily. Renal dose adjustment is required in patients with impaired renal function, as gabapentin is renally cleared without significant hepatic metabolism.
- Route: Oral only per this dosing description
- Titration: Gradual, over minimum 3 days at initiation; further weekly titration to effect
- Common adverse effects: Somnolence, dizziness, ataxia, fatigue, behavioral changes in children
- Monitoring: Sedation level, gait stability, mood/behavioral changes, renal function
- Contraindications/cautions: Known hypersensitivity to gabapentin; use with caution alongside other CNS depressants
- Max dose: Consult institutional protocol for per-dose and daily maximum limits in pediatric patients
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.